甲酸代谢产物酸与间歇性禁食协同作用,改善肥胖症
Sungjoon Oh1,2, Seokjae Park1,2, Eun-Kyoung Kim3,4
1Department of Brain Sciences, Daegu Gyeongbuk Institute of Science and Technology, Daegu, Republic of Korea.
Experimental & molecular medicine
|January 8, 2026
概括
将间歇性禁食 (IF) 与三酸 (TA) 结合起来,可以促进减肥,并改善肥胖小鼠的代谢健康. 这种组合有效地减少了食物摄入量,并通过向下丘脑神经来提高能量消耗.
科学领域:
- 代谢性疾病研究研究.
- 营养科学 营养科学
- 肥胖治疗方法 肥胖治疗方法
背景情况:
- 间歇性禁食 (IF) 是一种公认的肥胖治疗方法,但与药理方法相比,它的疗效是适度的.
- IF与营养物质衍生代谢物的结合作用尚不清楚.
- 了解协同策略对于提高肥胖治疗结果至关重要.
研究的目的:
- 为了研究间歇性禁食 (IF) 与三酸 (TA) 结合对肥胖的协同效应.
- 在饮食诱导的肥胖小鼠中探索TA和IF联合治疗的潜在机制.
- 评估对体重,食物摄入量,能量消耗和血糖控制的影响.
主要方法:
- 饮食诱导的肥胖小鼠接受了IF,TA或两者的组合治疗.
- 监测了体重,食物摄入量和能量消耗.
- 分析了下丘脑神经表达 (NPY,AGRP) 和葡萄糖转运体3 (GLUT3) 的活性.
主要成果:
- 与单独干预相比,IF和TA的组合导致体重和食物摄入量显著减少.
- 联合治疗改善了肥胖小鼠的能量消耗和血糖控制.
- 通过与葡萄糖竞争GLUT3吸收,TA逆转了低谷底氧原性神经 (NPY,AGRP) 的禁食诱导上调.
结论:
- 将间歇性禁食 (IF) 与三酸 (TA) 结合起来,为肥胖治疗提供了增强的治疗效益.
- 这种基于代谢物的组合策略有效地抑制食欲并改善代谢参数.
- 这些发现表明IF + TA是增强肥胖治疗疗效的有希望的方法.
更多相关视频
13:09Rapid Model to Evaluate the Anti-Obesity Potential of a Combination of Syzygium aromaticum Clove and Cuminun cyminum Cumin on C57BL6/j Mice Fed High-Fat Diet
Published on: July 31, 2021
4.0K
06:28A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
Published on: April 28, 2023
1.3K
相关概念视频
01:24Metabolic States of the Body: Fasting and Starvation
2.7K
During the initial hours of fasting, the body uses up its glycogen stores as an energy source. Once these glycogen reserves are depleted, the body begins breaking down stored triglycerides and structural proteins. During this stage, glycerol becomes a key substrate for gluconeogenesis, while free fatty acids undergo beta-oxidation to provide energy for tissues, such as skeletal muscle. In the fasting state, the body spares protein breakdown as much as possible to conserve muscle and structural...
2.7K
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
165
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
165
01:24Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
01:21Drug Dosing: Obese Patients
217
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
217
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
235
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
235
01:06Fats as Energy Storage Molecules
26.8K
Triglycerides are a form of long-term energy storage molecules. They are made of glycerol and three fatty acids. To obtain energy from fat, triglycerides must first be broken down by hydrolysis into their two principal components, fatty acids and glycerol. This process, called lipolysis, takes place in the cytoplasm. The resulting fatty acids are oxidized by β-oxidation into acetyl-CoA, which is used by the Krebs cycle. The glycerol that is released from triglycerides after lipolysis...
26.8K